Acute Methotrexate Neurotoxicity: Findings on Diffusion-Weighted Imaging and Correlation with Clinical Outcome
AJNR 25:1688-1695, Rollins,N.,et al, 2004
Primary Leptomeningeal Lymphoma
Neurol 81:1690-1696, Taylor, J.W.,et al, 2013
Central Nervous System Relapse in Non-Hodgkin Lymphoma
Arch Neurol 54:854-859, Bollen,E.L.E.M.,et al, 1997
Chronic Lymphocytic Leukemia and the Central Nervous System:A clinical and Pathological Study
Neurol 46:19-25, Cramer,S.C.,et al, 1996
Leptomeningeal Carcinomatosis:Presenting Features and Prognostic Factors
Arch Neurol 53:626-632, Balm,M.&Hammack,J., 1996
Primary Meningeal B Lymphoma Presenting as a Subacute Ascending Polyradiculoneuropathy
JNNP 54:610-613, Julien,J.,et al, 1991
Nosocomial Bacterial Meningitis
NEJM 362:146-154, van de Beek,D.,et al, 2010
Neurotoxocity of Intrathecal Methotrexate: MR Imaging Findings
AJNR 24:1887-1890, Sandoval,C.,et al, 2003
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
Brain Tumors
NEJM 324:1471-1476, 1555-15641991., Black,P.McL., 1991
Stroke-Like Syndrome, Mineralizing Microangiopathy, and Neuroaxonal Dyst with Intrathecal Methotrexate
Neurol 41:1847-1848, Phanthumchinda,K.,et al, 1991
Central Nervous System Lesions in Childhood Leukemia
Neurol 28:678, Crosley,C.J.,et al, 1978